CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s diseaseKanta Horie, Randall J. Bateman, Gemma Salvadó et al.|Nature Medicine|2023Cited by 249
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s diseaseErik C. B. Johnson, Yudy Milena Leon, Thomas S. Wingo et al.|Nature Medicine|2023Cited by 172
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s diseaseNicolas R. Barthélemy, Suzanne E. Schindler, Benjamin Saef et al.|Nature Aging|2023Cited by 150
Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive ImpairmentShorena Janelidze, Oskar Hansson, Nicolas R. Barthélemy et al.|JAMA Neurology|2024Cited by 109
Disease staging of Alzheimer’s disease using a CSF-based biomarker modelGemma Salvadó, Oskar Hansson, Kanta Horie et al.|Nature Aging|2024Cited by 108